期刊文献+

玄参中环烯醚萜Epibueropyridinium A对醛糖还原酶的抑制作用 被引量:19

Inhibitory effect of Epibueropyridium A extracted from scrophularia ningpoensis on aldose reductase
下载PDF
导出
摘要 目的:研究Epibueropyridium A对醛糖还原酶的抑制作用。方法:醛糖还原酶通过硫酸铵分级沉淀从牛眼晶状体中提取,在含有DL-甘油醛、醛糖还原酶、NADPH的反应体系中,加入一定浓度的Epibueropyridium A,通过340 nm处光密度的变化来反映Epibueropyridium A对酶活性的抑制作用。阳性对照为依帕司他,采用双倒数作图的方法确定抑制类型,二次作图法求Ki,以抑制剂浓度对抑制率作图求IC50。结果:Epibueropyridium A能显著抑制醛糖还原酶的活性,为竞争性抑制,其半数抑制剂量IC50为4.2μg/ml,Ki值为4.88μg/ml。结论:Epibueropyridium A是醛糖还原酶的竞争性抑制剂。 Objective: To investigate the inhibitory effect of Epibueropyridinium A on aldose reductase. Methods: Aldose reductase was extracted from cattle crystalline lens. Besides Epibueropyridinium A, the reactive system also contained DL-glyceraldehyde, aldose reductase, and NADPH. The activity changes of aldose reductase were detected at 340 nm. Epalrestat was taken as the positive control. The inhibitory type, Ki and IC50 were determined by double reciprocal plot, quadratic drawing, and drawing of inhibitor's concentration to inhibitory ratio, respectively. Results: Epibueropyridinium A significantly inhibited the activity of aldose reductase in a competitive manner, with IC50 being 4.2 μg/ml and Ki being 4.88μg/ml. Conclusion.. Epibueropyridinium A is competitive inhibitor of aldose reductase.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2006年第7期760-762,共3页 Academic Journal of Second Military Medical University
基金 上海-SK研究发展基金(2004004-t)~~
关键词 Epibueropyridium A 玄参 醛糖还原酶 酶抑制剂 Epibueropyridinium A scrophularia ningpoensis aldose reductase enzyme inhibitors
  • 相关文献

参考文献5

二级参考文献30

  • 1杜冠华,裘月,田月娥,张均田.丹酚酸A对大鼠半乳糖性白内障形成的抑制作用[J].药学学报,1995,30(8):561-566. 被引量:23
  • 2刘长山,董砚虎,逄力男,沈守祥,朱禧星.中药黄芩甙与黄连素对糖尿病鼠醛糖还原酶活性作用的观察[J].中国糖尿病杂志,1996,4(3):163-166. 被引量:70
  • 3Yukichi Okutda, Kazuko Kawashima, Seiji Suzuki, et al.Restoration of nitric oxide production by aldose reductase inhibitor in human vascular endothelial cells cultured in high-glucose media[J]. Life Science, 1997,60(3):53-56.
  • 4Williamson JR, Chang K, Frangos M, et al. Hyperglycemic pseudohypoxia and diabetic complications[J]. Diabetes, 1993,42:801-813.
  • 5Kamiya H, Nakamura J, Hamada Y,et al. Polyol pathway and protein kinase C activity of rat Schwannoma cells[J]. Diabetes Metab Res Rev,2003,19(2):131-139.
  • 6Shaw S, Wang X, Redd H, et al. J Biol Chem,2003,30.
  • 7Inoguchi T, Pu T, Kunisaki M, et al. Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues[J]. Am J Physiol, 1994,267:E369-379.
  • 8Kawanishi K, Ueda H, Moriyasu M. Aldose reductase inhibitors from the nature[J].Curr Med Chem,2003,10(15):1353-1374.
  • 9Banditeltelli S,Boldrini E,Vilardop G,et al. A new approach against sugar cataract through aldose reductase inhibitors[J]. Exp Eye Res,1999, 69(5):533-538.
  • 10Obrosova IG,Van Huysen C,Fathallah L,et al. Evaluation of 1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense[J]. FASEB J,2001,14.

共引文献43

同被引文献217

引证文献19

二级引证文献307

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部